Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

47,092 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
First-in-human trial of engineered NK cells in lung cancer refractory to immune checkpoint inhibitors.
Villalona-Calero MA, Tian L, Li X, Palmer JM, Aceves C, Meisen H, Cortez C, Synold TW, Egelston C, VanDeusen J, Bruno I, Zhang L, Romeu-Bonilla E, Butt O, Forman SJ, Caligiuri MA, Yu J. Villalona-Calero MA, et al. Among authors: yu j. JCI Insight. 2025 Feb 4:e186890. doi: 10.1172/jci.insight.186890. Online ahead of print. JCI Insight. 2025. PMID: 39903538
RNase L represses hair follicle regeneration through altered innate immune signaling.
Kirby CS, Islam N, Wier E, Alphonse MP, Sweren E, Wang G, Liu H, Kim D, Li A, Lee SS, Overmiller AM, Xue Y, Reddy S, Archer NK, Miller LS, Yu J, Huang W, Jones JW, Kim S, Kane MA, Silverman RH, Garza LA. Kirby CS, et al. Among authors: yu j. J Clin Invest. 2025 Feb 4:e172595. doi: 10.1172/JCI172595. Online ahead of print. J Clin Invest. 2025. PMID: 39903537
47,092 results
You have reached the last available page of results. Please see the User Guide for more information.